Abdulazeez Salawu Selected Research

Drug Therapy (Chemotherapy)

1/2021	Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 Trial.
10/2019	When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Abdulazeez Salawu Research Topics

Disease

5	Neoplasms (Cancer) 10/2023 - 01/2020
4	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 01/2012
3	Leiomyosarcoma 10/2023 - 01/2012
2	Disease Progression 10/2023 - 01/2022
2	Melanoma (Melanoma, Malignant) 01/2018 - 07/2013
2	Liposarcoma 01/2018 - 10/2016
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Salivary Gland Neoplasms (Salivary Gland Cancer) 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Mesothelioma 12/2020
1	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 10/2019
1	Genomic Instability 01/2018
1	Phlebitis 01/2014
1	Uveal melanoma 07/2013

Drug/Important Bio-Agent (IBA)

2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2012
1	durvalumabIBA 10/2023
1	cediranib (AZD2171)IBA 10/2023
1	olaparibIBA 10/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2023
1	Immune Checkpoint InhibitorsIBA 10/2023
1	AntibodiesIBA 11/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	AfatinibIBA 01/2022
1	CytokinesIBA 12/2020
1	Immunoglobulin G (IgG)IBA 12/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	Cell-Free Nucleic AcidsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2018
1	Codon (Codons)IBA 07/2013
1	MitogensIBA 07/2013
1	Cyclin D1IBA 07/2013
1	ParaffinIBA 01/2012
1	OligonucleotidesIBA 01/2012
1	Formaldehyde (Formol)FDA Link 01/2012

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2021 - 10/2019
2	Radiotherapy 01/2021 - 10/2016
1	Immunotherapy 10/2023
1	Salvage Therapy 01/2023
1	Neoadjuvant Therapy 01/2021
1	Personal Protective Equipment 01/2020
1	Aftercare (After-Treatment) 10/2019
1	Cannula 01/2014
1	Intravenous Infusions 01/2014